Company: PTPI
Filing Date: 2025-01-24
Form Type: 8-K
Source: 0001104659-25-005980
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-01-24
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits

  Exhibit      Description                                                                                                 
   Number                                                                                                                  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Certificate of Amendment                                                                                    
     10.1      Form of Amendment Agreement,                                                                                
      104      Cover Page Interactive                                                                                      

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                              PETROS PHARMACEUTICALS, INC.                                                     
  Date: January 24, 2025      By:                               /s/ Fady Boctor                                
                                                                Name: Fady Boctor                              
                                                                Title: President and Chief Commercial Officer